BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28639897)

  • 21. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
    Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
    Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Chen X; Lan K; Liu Q; Yang X; Wang H
    Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
    Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
    Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
    Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
    Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk of hematogenous metastasis of cancer of the uterine cervix].
    Maassen V; Dieckhoff R; Baltzer J; Kindermann G
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):656-61. PubMed ID: 7851708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
    Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
    Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
    Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer.
    DeMei M; XiangXin L; YongPing X; YongXia Y; YunHai Y; Lin Z
    J Int Med Res; 2013 Oct; 41(5):1541-9. PubMed ID: 23963849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN.
    Xu J; Zhang W; Lv Q; Zhu D
    Oncol Rep; 2015 Jun; 33(6):3108-16. PubMed ID: 25963606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells.
    Zhang YX; Qin CP; Zhang XQ; Wang QR; Zhao CB; Yuan YQ; Yang JG
    Tumour Biol; 2017 Apr; 39(4):1010428317699119. PubMed ID: 28443476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
    Dong J; Sui L; Wang Q; Chen M; Sun H
    Mol Med Rep; 2014 Sep; 10(3):1426-32. PubMed ID: 24939702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M; Hentschel B; Horn LC
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells.
    Zhang L; Niyazi HE; Zhao HR; Cao XP; Abudula MN; Ye WJ; Zhang SA; Yiming RH; Zhang Y; Su WP; Chen R; Ouyang Y; Miao N; Bao YX
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
    Fu ZC; Wang FM; Cai JM
    Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
    Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
    Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.
    Li XR; Chu HJ; Lv T; Wang L; Kong SF; Dai SZ
    FEBS Lett; 2014 Aug; 588(17):3298-307. PubMed ID: 25066298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.